Antonio V.
- Country
- Italy
- Department
- Department of Mental Health and Addiction Services
Research Overview
- Evaluation of Intensified Pharmacological Treatment with Esketamine for Major Depressive Disorder in Patients with First-Line Treatment Failure
- Evaluation of Intensified Pharmacological Regimen with Lithium, Sertraline, and Bupropion Hydrochloride in Bipolar Depression Post First-Line Treatment Failure
- Evaluation of Intensified Pharmacological Regimen with Clozapine and Drug Combination in Schizophrenia Patients Experiencing First-Line Treatment Failure
Data & Insights
Has run more than one trial at 27 of 133 partner sites.
Specializations
Mood Disorders
The investigator specializes in the treatment of major depressive disorder with particular focus on managing treatment-resistant cases and innovative therapeutic approaches.
- Treatment-resistant depression
- Adjunctive therapy approaches
- Depression with comorbid insomnia
Clinical expertise extends to evaluating novel pharmacological interventions for patients who have experienced first-line treatment failures.
Psychotic Disorders
Focused on advancing treatment methodologies for schizophrenia spectrum disorders, including schizoaffective and schizophreniform conditions.
- Early intervention strategies
- Treatment-resistant schizophrenia
- Symptom severity management
Specializes in intensified pharmacological approaches for patients who have not responded to initial treatments.
Bipolar Spectrum
Conducts research in the management of bipolar depression with emphasis on developing enhanced treatment protocols.
- Bipolar depression interventions
- Treatment optimization strategies
- Early response assessment
Investigates intensified therapeutic approaches for bipolar disorder patients who experience inadequate response to first-line treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.